EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $386,000 | -55.0% | 9,085 | -40.1% | 0.01% | -68.2% |
| Q3 2019 | $858,000 | -0.7% | 15,173 | -2.2% | 0.02% | +29.4% |
| Q2 2019 | $864,000 | +14.4% | 15,512 | +3.7% | 0.02% | -10.5% |
| Q1 2019 | $755,000 | +167.7% | 14,952 | +267.6% | 0.02% | +280.0% |
| Q3 2018 | $282,000 | +12.8% | 4,068 | +23.0% | 0.01% | +25.0% |
| Q2 2018 | $250,000 | +4.6% | 3,307 | -27.2% | 0.00% | 0.0% |
| Q1 2018 | $239,000 | +6.2% | 4,542 | +7.9% | 0.00% | 0.0% |
| Q4 2017 | $225,000 | -65.4% | 4,210 | -49.0% | 0.00% | -60.0% |
| Q2 2017 | $651,000 | +25.9% | 8,258 | +32.6% | 0.01% | +42.9% |
| Q1 2017 | $517,000 | – | 6,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |